Febrile young infant: documentation that holds up
A fever in the first two months of life is an age-driven algorithm, not a gestalt call. Exam and observation scales are unreliable in this group, so the defensible chart documents the exact age in days, the route of the temperature, the age-based workup completed or deferred, and the shared decision behind any deferral.
01What's at stake
Roughly 10% of febrile infants ≤60 days have a urinary tract infection, ~2% have bacteremia, and ~0.4% have bacterial meningitis — and a well appearance does not lower that risk enough to skip testing. Bacterial meningitis is the most common diagnosis in pediatric ED malpractice claims, and the WBC was normal in about 41% of infants with meningitis. Fever may be the only sign.
02Can't-miss infections
- UTI / pyelonephritis — the most common (~10%).
- Bacteremia and bacterial meningitis — the invasive bacterial infections; rarer but devastating.
- Neonatal HSV — rare but lethal; a negative maternal history does not exclude it.
The algorithm applies to well-appearing, full-term, previously healthy infants. Any ill-appearing infant — and effectively all infants ≤21 days — gets the full workup and admission regardless of labs.
03The age-based approach
- 8–21 days: full workup — blood culture, urine (cath), and CSF; admit on empiric antibiotics regardless of markers; consider HSV testing/acyclovir. → everyone
- 22–28 days: blood culture, urine, inflammatory markers; LP if any marker abnormal, shared decision-making if normal; disposition driven by CSF.
- 29–60 days: blood culture, urine, inflammatory markers; if markers and UA are normal → discharge with no LP/antibiotics and 24-hour follow-up; abnormal UA → treat UTI; abnormal markers → LP/admit.
- Inflammatory markers: procalcitonin >0.5, ANC >4000 (with PCT) / >5200 (without), CRP ≥20 mg/L, temp >38.5°C. WBC/bands are no longer used for risk stratification.
Skip the typing
Work the case in the Febrile Infant Workup — it records age/appearance, the workup completed, inflammatory markers, the LP decision, empiric antibiotics, and HSV coverage, and assembles an MDM that documents the age-based pathway.
04HSV & antibiotics
- Suspect/treat HSV (PCRs + IV acyclovir) in any ill-appearing, hypothermic, or seizing infant; with vesicles, transaminitis, CSF pleocytosis, or thrombocytopenia; and consider it broadly in infants ≤21 days. Vesicles are absent in many cases — don't wait for them. Each day's delay in acyclovir increases mortality.
- Empiric antibiotics: ≤21 days → ampicillin + (ceftazidime or gentamicin), avoid ceftriaxone; 22–60 days → ceftriaxone (add ampicillin and adjust if meningitis suspected).
05What to document
06Where charts fail
- Letting a well appearance defer the workup — it doesn't lower the risk enough.
- Dismissing a home rectal fever as "bundling," or trusting a normal WBC to exclude meningitis.
- Giving antibiotics before the LP and sterilizing the CSF in a low-risk infant.
- Missing HSV because there were no vesicles or no maternal history.
- Discharging without a confirmed reliable caregiver and arranged 24-hour follow-up.
07Sources
- Palladino L, Woll C, Aronson PL. Febrile infants aged ≤60 days: evaluation and management in the emergency department. Pediatric Emergency Medicine Practice (EB Medicine). 2024;21(2).
- Pantell RH, Roberts KB, Adams WG, et al. Evaluation and management of well-appearing febrile infants 8 to 60 days old. Pediatrics. 2021;148(2):e2021052228.
- Kuppermann N, Dayan PS, Levine DA, et al. A clinical prediction rule to identify febrile infants ≤60 days at low risk for serious bacterial infections. JAMA Pediatr. 2019;173(4):342-351.
- Gomez B, Mintegi S, Bressan S, et al. Validation of the "Step-by-Step" approach in the management of young febrile infants. Pediatrics. 2016;138(2):e20154381.
© 2026 Kim Trinh, MD. All rights reserved. Educational only — synthesized from EB Medicine, the 2021 AAP guideline, and primary literature. Synthetic examples. Not medical advice — apply local protocol and judgment.